by John Conrad | Aug 1, 2024 | NewsBrief
In a significant move to boost scientific innovation and commercialization, Portal Innovations is partnering with the University of Chicago’s Polsky Center for Entrepreneurship and Innovation to create a new science startup incubator. The collaboration will see...
by John Conrad | Jun 17, 2024 | NewsBrief
John Flavin, CEO of Portal Innovations, recently appeared on CNBC’s Fast Money to discuss GLP-1 drugs, early-stage biotech investing, and Portal’s unique investment model. On the topic of GLP-1 drugs for obesity and diabetes, Flavin noted that while there...
by John Conrad | Sep 19, 2022 | iBIO in the News
Although Chicago is the third largest city in the United States, when it comes to its position as a leading biotech hub, the second city ranks far below many other U.S. locations. That is starting to change, however, as new companies move into this heart of...